Name: Sui, Guangchao
Degree: Ph.D.
Title: Professor
Phone number: 86-451-8219-1081
E-mail: gcsui@nefu.edu.cn
Address: Northeast Forestry University, Shaw (Yifu) Teaching Building, Room 117
Education and Training:
1983 – 1987: Peking University, Bachelor of Science in Biochemistry
1990 – 1995: Peking University, Ph.D. in Biochemistry and Molecular Biology
1995 – 1998: Karolinska Institute, Sweden, Ph.D. in Medicine
1998 – 1999: Karolinska Institute, Sweden, Postdoctoral Training in Clinical Chemistry
1999 – 2004: Harvard Medical School, Postdoctoral Training in Pathology
Employment:
1987 – 1990: Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Research Assistant
2004 – 2005: Harvard Medical School, Department of Pathology, Instructor
2005 – 2012: Wake Forest School of Medicine, Department of Cancer Biology, NIH Comprehensive Cancer Center, Assistant Professor
2012 – 2014: Wake Forest School of Medicine, Department of Cancer Biology, NIH Comprehensive Cancer Center, Associate Professor
2014 – Current: Northeastern Forestry University, College of Life Science, Professor
Honors and Awards:
2002 - 2004 NIH National Research Service Awards, Viral Oncology Training Grant (T32CA09031).
2007 – 2010 New Investigator Award from Department of Defense
2014, 2015 and 2016, Silver Awards for three years, International Genetic Engineering Machine Competition (iGEM). As a team leader and instructor.
2017-2022, Gold Award, International Genetic Engineering Machine Competition (iGEM). As a team leader and instructor.
Research Specialty:
Molecular Biology, Cell Biology, Biochemistry, Epigenetics, Cancer Biology, Non-coding RNA
Courses to Teach:
Biochemistry and Molecular Biology, Epigenetics, Development Biology (Cancer-related)
Extramural Appointments and Service:
1) Department of Defense: Endocrinology Peer Review Panel of Prostate Cancer Research Program (Member, 2008)
2) Department of Defense: Clinical Health Science and Epidemiology online pre-proposal review panel of Prostate Cancer Research Program (Member, 2009)
3) Department of Defense: Genetic Cancer (GC) peer review panel (Member, 2010)
4) Department of Defense: Clinical Health Science and Epidemiology online pre-proposal review panel of Prostate Cancer Research Program (Member, 2010)
5) Department of Defense: Pathobiology peer review panel (Member, 2010)
6) Department of Innovation: General Directorate for Health and Technologies Research, Italian Ministry of Health, Republic of Italy (Member, 2010)
7) Department of Defense: Prostate Cancer Exploration-Hypothesis Development Program (Cell and Molecular Biology) (Member, 2011)
8) Department of Defense: CDMRP Breast Cancer Research Program (BCRP) (Member, 2011)
9) The Prostate Cancer UK Research Awards Spring 2012 (Member, 2012)
10) Department of Defense: Prostate Cancer Research Program, Exploration-Hypothesis Development-Pathobiology-2 (Member, 2012)
11) American Cancer Society: Tumor Biology and Genomics (Member, 2013)
12) Department of Defense: Breast Cancer Research Program Training-2 Molecular Biology (Member, 2013)
13) Department of Innovation: General Directorate for Health and Technologies Research, Italian Ministry of Health, Republic of Italy (Member, 2013)
14) Scientific reviewer for US Department of Defense: Prostate Cancer Research Program - Laboratory Clinical Transition (Member, 2013)
15) Scientific reviewer for US Department of Defense: Breast Cancer Research Program Training-2 Cell and Molecular Biology (Member, 2014)
16) Scientific reviewer for Department of Innovation: General Directorate for Health and Technologies Research, Italian Ministry of Health, Republic of Italy (Member, 2014)
17) Scientific reviewer for Department of Innovation: General Directorate for Health and Technologies Research, Italian Ministry of Health, Republic of Italy (Member, 2016)
18) Scientific reviewer for National Natural Science Foundation of China (Member, 2019)
19) National Natural Science Foundation of China (2019-2021)
20) Ministry of Science and Technology (2021)
Journal Reviewer:
As a reviewer for the following journals: Am J Pathol, Biochem J, Cancer Res, FEBS Letters, Mol Cell Biol, Oncogene, PNAS, PLoS One, Neoplasia, etc.
Editorial Boards:
American Journal of Cancer Biology (Senior Editorial Board) (since 2012)
European Journal of Molecular Biology (since 2012)
Journal of Oncobiomarkers (since 2012)
Research Interest:
My research interest is Epigenetic Regulation in Cancer Biology, with the focuses on functional studies of novel oncogenes and tumor suppressors. Our work suggested an oncogenic role of Yin Yang 1 (YY1) through negatively regulating p53 and p27 tumor suppressors and the regulation is independent of YY1’s transcriptional activity. I invented the DNA vector-based RNAi vector (shRNA), the first generation of pSilencer (a product of Ambion, Inc.). The PNAS paper for this approach has been cited over 1,000 times and this technology has become a common technique in most research labs. We are also investigating functional roles of other tumor suppressive proteins and oncogenes, including noncoding RNAs, in cancers.
Our current research focuses include (1) Molecular mechanism for the anticancer activities of plant compounds and their combinatorial use with chemotherapeutics in cancer treatment. (2) G-quadruplex: formation, function and regulatory mechanism. (3) Molecular mechanism of YY1-mediated enhancer activity in regulating gene expression. (4) Tumor suppressors and oncogenes: molecular mechanisms and potential targeting sites for cancer therapies.
Funding:
(1) National Natural Science Foundation of China (82273107) (Sui, P.I.)
01/01/2023 – 12/31/2026
Title: A systematic investigation of the splicing factors and molecular mechanism regulating the alternative splicing of the DMTF1 pre-mRNA in breast cancer
(2) National Natural Science Foundation of China (81872293) (Sui, P.I.)
01/01/2019 – 12/31/2022
Title: Determine the Characteristics of G-quadruplex Formation in the Genome of Breast Cancer Cells and its Regulatory Factors
(3) National Natural Science Foundation of China (8167111392) (Sui, P.I.)
01/01/2017 – 12/31/2020
Title: The mechanism and application of YY1-regulated oncogene activity in breast cancer
(4) National Natural Science Foundation of China (81472635) (Sui, P.I.)
01/01/2015 – 12/31/2018
Title: The Regulatory Mechanism of SOX7 in Breast Cancer
(5) National Natural Science Foundation of Heilongjiang, China (ZD2015004) (Sui, P.I.)
07/01/2015 – 07/01/2018
Title: The application of the YY1-OPB peptide in inhibiting tumor growth
Publications: (* as a corresponding author)
1. Guangyue Li, Gongbo Su, Yunxuan Wang, Wenmeng Wang, Jinming Shi, Dangdang Li and Guangchao Sui*. Integrative genomic analyses of promoter G-quadruplexes reveal their selective constraint and association with gene activation. Commun Biol. (2023) 10;6(1):625.
https://doi.org/10.1038/s42003-023-05015-6
2. Jiahui Cheng, Guangyue Li, Wenmeng Wang, Daniel B Stovall, Guangchao Sui*, Dangdang Li*. Circular RNAs with protein-coding ability in oncogenesis. Biochim Biophys Acta Rev Cancer. (2023) 1878(4):188909.
https://doi.org/10.1016/j.bbcan.2023.188909
3. Umar Farooq, Hao Wang, Jingru Hu, Guangyue Li, Shah Jehan, Jinming Shi, Dangdang Li* and Guangchao Sui*. Polydatin Inhibits Hepatocellular Carcinoma Cell Proliferation and Sensitizes Doxorubicin and Cisplatin through Targeting Cell Mitotic Machinery. Cells. (2023) 2023, 12(2):222.
https://doi.org/10.3390/cells12020222
4. Wenmeng Wang, Shiyao Qiao, Guangyue Li, Jiahui Cheng, Cuicui Yang, Chen Zhong, Daniel B. Stovall, Jinming Shi, Chunbo Teng, Dangdang Li* and Guangchao Sui*. A histidine cluster determines YY1-compartmentalized coactivators and chromatin elements in phase-separated enhancer clusters. Nucleic Acids Res. (2022) 50(9):4917-4937.
https://doi.org/10.1093/nar/gkac233
5. Shiyao Qiao, Wenmeng Wang, Cheng Yi, Qingqing Xu, Wenfei Wang, Jinming Shi, Daniel B. Stovall, Dangdang Li and Guangchao Sui*. YY1 Oligomerization Is Regulated by Its OPB Domain and Competes with Its Regulation of Oncoproteins. Cancers. (2022) 14, 1611.
https://doi.org/10.3390/cancers14071611
6. Yaoyao Liang, Juan Luo, Chenhao Yang, Shuning Guo, Bowen Zhang, Fengqianrui Chen, Kairui Su, Yulong Zhang, Yi Dong, Zhihao Wang, Hongda Fu, Guangchao Sui* and Pengchao Wang*. Directed evolution of the PobR allosteric transcription factor to generate a biosensor for 4-hydroxymandelic acid. World J Microbiol Biotechnol. (2022) 38(6):104.
https://doi.org/10.1007/s11274-022-03286-5
7. Lin Zhang, Shubo Wang, Wenmeng Wang, Jinming Shi, Daniel B. Stovall, Dangdang Li,* and Guangchao Sui*. Phase-Separated Subcellular Compartmentation and Related Human Diseases. Int J Mol Sci. (2022) 23(10):5491.
https://doi.org/10.3390/ijms23105491
8. Jinhua Wang, Dangdang Li, Bo Zhao, Juhyok Kim, Guangchao Sui* and Jinming Shi*. Small Molecule Compounds of Natural Origin Target Cellular Receptors to Inhibit Cancer Development and Progression. Int J Mol Sci. (2022) 23:2672.
https://doi.org/10.3390/ijms23052672
9. Cheng Yi, Guangyue Li, Wenmeng Wang, Yixuan Sun, Yueling Zhang, Chen Zhong, Daniel B. Stovall, Dangdang Li, Jinming Shi* and Guangchao Sui*. Disruption of YY1-EZH2 Interaction Using Synthetic Peptides Inhibits Breast Cancer Development. Cancers. (2021) 13(10):2402.
http://dx.doi.org/doi:10.3390/cancers13102402
10. Jialiang Li, Guangyue Li, Yige Qi, Yao Lu, Hao Wang, Ke Shi, Dangdang Li, Jinming Shi, Daniel B. Stovall and Guangchao Sui*. SRSF5 Regulates Alternative Splicing of DMTF1 pre-mRNA through Modulating SF1 Binding. RNA Biology. (2021) 18(sup1):318-336.
http://dx.doi.org/doi:10.1080/15476286.2021.1947644
11. Aixin Hao, Yunxuan Wang, Daniel B. Stovall, Yu Wang* and Guangchao Sui*. Emerging Roles of LncRNAs in the EZH2-regulated Oncogenic Network. Int J Biol Sci. (2021) 17(13):3268-3280.
http://dx.doi.org/doi:10.7150/ijbs.63488
12. Bo Zhao, Jinyan Zhao, Mingshuai Lv, Xiaoyan Li, Jinhua Wang, Zhengrong Yue, Jinming Shi, Guocai Zhang* and Guangchao Sui*. Comparative study of structural properties and biological activities of polysaccharides extracted from Chroogomphus rutilus by four different approaches. Int J Biol Macromol. (2021) 188:215-225.
http://dx.doi.org/doi:10.1016/j.ijbiomac.2021.08.025
13. Aixin Hao, Yu Wang, Xiao Zhang, Jialiang Li, Yingzhou Li, Dangdang Li, George Kulik and Guangchao Sui*. Long Non-coding Antisense RNA HYOU1-AS is Essential to Human Breast Cancer Development Through Competitive Binding hnRNPA1 to Promote HYOU1 Expression. Biochim Biophys Acta - Mol Cell Res. (2021) 1868(4):118951.
http://dx.doi.org/doi:10.1016/j.bbamcr.2021.118951
14. Qiong Wu, Bo Zhao, Guangchao Sui* and Jinming Shi*. Phytochemicals block glucose utilization and lipid synthesis to counteract metabolic reprogramming in cancer cells. Applied Sciences. (2021) 11:1259.
https://doi.org/10.3390/app11031259
15. Albert Gyapong Aduhene, Hongliang Cui, Hongyi Yang, Chengwei Liu, Guangchao Sui* and Changli Liu*. Poly(3-hydroxypropionate): Biosynthesis Pathways and Malonyl-CoA Biosensor Material Properties. Front Bioeng Biotech. (2021) 9:646995.
http://dx.doi.org/doi:10.3389/fbioe.2021.646995
16. Shuang Qiu, Chen Zhong, Bo Zhao, Guangyue Li, Jinhua Wang, Shah Jehan, Jialiang Li, Xudong Zhao, Dangdang Li and Guangchao Sui*. Transcriptome Analysis of Signaling Pathways Targeted by Ellagic Acid in Hepatocellular Carcinoma Cells. Biochim Biophys Acta – General Subjects. (2021) 1865(7):129911.
http://dx.doi.org/doi:10.1016/j.bbagen.2021.129911
17. Lanlan Zhang, Ting Yan, Wenmeng Wang, Qiong Wu, Guangyue Li, Dangdang Li, Daniel B Stovall, Yunxuan Wang, Yuhua Li* and Guangchao Sui*. AKT1 is positively regulated by G-quadruplexes in its promoter and 3'-UTR. Biochem Biophys Res Commun. (2021) 561:93-100.
http://dx.doi.org/doi:10.1016/j.bbrc.2021.05.029
18. Tianyan Liu, Yu Zhang, Yukai Cao, Shan Jiang, Rui Sun, Jiechao Yin, Zhenqiu Gao, Guiping Ren, Zhenzhong Wang, Qingzhong Yu, Guangchao Sui, Xu Sun, Wenying Sun, Wei Xiao and Deshan Li. Optimization of oncolytic effect of Newcastle disease virus Clone30 by selecting sensitive tumor host and constructing more oncolytic viruses. Gene Therapy. (2020) 28(12):697-717.
http://dx.doi.org/doi:10.1038/s41434-020-0145-9
19. Yunxuan Wang, Ting Yan, Jialiang Li, Wenmeng Wang, Qiong Wu, Jinming Shi, Dangdang Li, Daniel B. Stovall, Qingyuan Zhang* and Guangchao Sui*. The SNAIL1 promoter contains G-quadruplex structures regulating its gene expression and DNA replication. Exp Cell Res. (2020) 394(2):112158.
http://dx.doi.org/doi:10.1016/j.yexcr.2020.112158
20. Wenmeng Wang, Shuangli Hu, Yaru Gu, Yunxiao Yan, Daniel B. Stovall, Dangdang Li* and Guangchao Sui*. Human MYC G-quadruplex: From discovery to a cancer therapeutic target. Biochim Biophys Acta - Rev Cancer. (2020) 1874(2):188410.
http://dx.doi.org/doi:10.1016/j.bbcan.2020.188410
21. Shah Jehan, Chen Zhong, Guangyue Li, Syed Zulqarnain Bakhtiar, Dangdang Li* and Guangchao Sui*. Thymoquinone selectively induces hepatocellular carcinoma cell apoptosis in synergism with clinical therapeutics and dependence of p53 status. Front Pharmacol., (2020) 11:555283.
http://dx.doi.org/doi:10.3389/fphar.2020.555283
22. Sazzad Hassan, Ashok Pullikuth, Kyle C Nelson, Anabel Flores, Yelena Karpova, Daniele Baiz, Sinan Zhu, Guangchao Sui, Yue Huang, Ralph D'Agostino, Ashok Hemal, Urs von Holzen, Waldemar Debinski and George Kulik. Beta2-adrenoreceptor signaling increases therapy-resistance in prostate cancer by upregulating MCL1. Mol Cancer Res, (2020) 18(12):1839-1848.
http://dx.doi.org/doi:10.1158/1541-7786.MCR-19-1037
23. Jialiang Li, Ke Shi, Tianqi Xu, Jingru Hu, Tianxin Li, Guangyue Li, Kuida Chen, Dangdang Li, Kazushi Inoue and Guangchao Sui*. Mechanisms regulating DMTF1β/γ expression and their functional interplay with DMTF1α. Int J Oncol., (2020) 58(1):20-32.
http://dx.doi.org/doi:10.3892/ijo.2020.5146
24. Ting Yan, Bo Zhao, Qiong Wu, Wenmeng Wang, Jinming Shi, Dangdang Li, Daniel B. Stovall and Guangchao Sui*. Characterization of G-quadruplex formation in the ARID1A promoter. Int J Biol Macromol. (2020) 147:750-761.
http://dx.doi.org/doi:10.1016/j.ijbiomac.2020.01.210
25. Dangdang Li, Daniel B. Stovall B, Wenmeng Wang and Guangchao Sui*. Advances of Zinc Signaling Studies in Prostate Cancer. Int J Mol Sci. (2020) 21(2):667.
http://dx.doi.org/doi:10.3390/ijms21020667
26. Yige Qi, Ting Yan, Lu Chen, Qiang Zhang, Weishu Wang, Xu Han, Dangdang Li, Jinming Shi and Guangchao Sui*. Characterization of YY1 OPB Peptide for Its Anticancer Activity, Current Cancer Drug Targets, (2019) 19(6):504-511.
http://dx.doi.org/doi:10.2174/1568009618666181031153151
27. Chen Zhong, Shuang Qiu, Jialiang Li, Jingling Shen, Yuangang Zu, Jinming Shi* and Guangchao Sui*. Ellagic acid synergistically potentiates inhibitory activities of chemotherapeutic agents to human hepatocellular carcinoma. Phytomedicine, (2019) 59:152921.
http://dx.doi.org/doi:10.1016/j.phymed.2019.152921
28. Kuida Chen, Yao Lu, Ke Shi, Daniel B. Stovall, Dangdang Li and Guangchao Sui*. Functional analysis of YY1 zinc fingers through cysteine mutagenesis. FEBS Letters, (2019) 593(12):1392-1402.
http://dx.doi.org/doi:10.1002/1873-3468.13431
29. Shuting Lu, Liping Liu, Henan Wang, Wancheng Zhao, Zeyu Li, Zheng Qu, Jialu Li, Tiedong Sun, Ting Wang and Guangchao Sui. Synthesis of dual functional gallic-acid-based carbon dots for bioimaging and antitumor therapy. Biomaterials Science, (2019) 7(8):3258-3265.
http://dx.doi.org/doi:10.1039/c9bm00570f
30. Yumeng Zhang, Daniel B. Stovall, Meimei Wan, Qiang Zhang, Jeff W. Chou, Dangdang Li and Guangchao Sui*. SOX7 Target Genes and Their Contribution to Its Tumor Suppressive Function. Int. J. Mol. Sci. (2018) 19(5):pii: E1451.
http://dx.doi.org/doi:10.3390/ijms19051451
31. Yingzhou Li, Xiao Zhang, Yang Gao, Jiming Shi, Liping Tang* and Guangchao Sui*. G-quadruplexes in the BAP1 promoter positively regulate its expression. Exp. Cell. Res. (2018) 369(1):147-15.
http://dx.doi.org/doi:10.1016/j.yexcr.2018.05.016
32. Jeffrey P Chmielewski, Sarah Bowlby, Frances Wheeler, Lihong Shi, Guangchao Sui, Amanda L. Davis, Timothy Howard, Ralph B. D'Agostino, Lance Miller, S. Joseph Sirintrapun, Scott Cramer and Steven J. Kridel. CD38 Inhibits Prostate Cancer Metabolism and Proliferation by Reducing Cellular NAD+ Pools. Mol. Cancer. Res. (2018) 16(11):1687-1700.
http://dx.doi.org/DOI:10.1158/1541-7786.MCR-17-0526
33. Xiao Zhang, Bo Zhao, Ting Yan, Aixin Hao, Yang Gao, Dangdang Li and Guangchao Sui*. G-Quadruplex Structures at the Promoter of HOXC10 Regulate its Expression. BBA-Gene Regul. Mech., (2018) 1861(11):1018-1028.
http://dx.doi.org/doi:10.1016/j.bbagrm.2018.09.004
34. Na Tian, Jialiang Li, Jinming Shi and Guangchao Sui*. From General Aberrant Alternative Splicing in Cancers and Its Therapeutic Application to the Discovery of an Oncogenic DMTF1 Isoform. (2017) Int. J. Mol. Sci. 18(191):1-20.
http://dx.doi.org/doi:10.3390/ijms18030191
35. Wenmeng Wang, Dangdang Li and Guangchao Sui*. YY1 Is an Inducer of Cancer Metastasis. Crit. Rev. Oncog. (2017) 22(1-2):1-11.
http://dx.doi.org/doi:10.1615/CritRevOncog.2017021314
36. Li Yao*, Heming Wang, Yuanyuan Song and Guangchao Sui*. BioQueue: a novel pipeline framework to accelerate bioinformatics analysis. Bioinformatics. (2017) 33(20):3286-3288.
http://dx.doi.org/doi:10.1093/bioinformatics/btx403
37. Chen Zhong, Nathan R. Wall, Yuangang Zu and Guangchao Sui*. Therapeutic Application of Natural Medicine Monomers in Cancer Treatment. Curr. Med. Chem. (2017) 24(34):3681-3691.
http://dx.doi.org/doi:10.2174/0929867324666170714101503
38. Qiang Zhang, Meimei Wan, Jinming Shi, David A. Horita, Lance D. Miller, Timothy E. Kute, Steven J. Kridel, George Kulik, and Guangchao Sui*. Yin Yang 1 Promotes mTORC2-mediated AKT Phosphorylation. J. Mol. Cell. Biol. (2016) 8(3):232-243.
http://dx.doi.org/doi:10.1093/jmcb/mjw002
39. Jingxuan Wang, Xiao Zhang, Jinming Shi, Paul Cao, Meimei Wan, Qiang Zhang, Yunxuan Wang, Steven J. Kridel, Wennuan Liu, Jianfeng Xu, Qingyuan Zhang and Guangchao Sui*. Fatty Acid Synthase is a Primary Target of MiR-15a and MiR-16-1 in Breast Cancer. Oncotarget. (2016) 7(48):78566-78576.
http://dx.doi.org/doi:10.18632/oncotarget.12479
40. Dejan Maglic, Daniel B. Stovall, Mark Cline, Elizabeth A. Fry, Ali Mallakin, Pankaj Taneja, David L. Caudell, Mark C. Willingham, Guangchao Sui*, and Kazushi Inoue*. DMP1β, a splice isoform of the tumor suppressor DMP1 locus, induces proliferation and progression of breast cancer. J. Pathol. (2015) 236(1):90-102.
http://dx.doi.org/doi:10.1002/path.4504
41. Jinming Shi, Aixin Hao, Qiang Zhang, and Guangchao Sui*. The Role of YY1 in Oncogenesis and Its Potential as a Drug Target in Cancer Therapies. Current Cancer Drug Targets. (2015) 15(2):145-157.
http://dx.doi.org/10.2174/1568009615666150131124200
42. Wei Wang, Zhiyong Deng, Heather Hatcher, Lance D. Miller, Xiumin Di, Lia Tesfay, Guangchao Sui, Ralph B. D'Agostino Jr., Frank M. Torti, and Suzy V. Torti. IRP2 regulates breast tumor growth. Cancer Research. (2014) 74(2):497-507.
http://dx.doi.org/doi:10.1158/0008-5472.CAN-13-1224
43. Nicholas R. Galloway, Carlos J. Diaz Osterman, Karl Reiber, Jessica M.S. Jutzy, Fengzhi Li, Guangchao Sui, Ubaldo Soto, Nathan R. Wall. Yin Yang 1 regulates the transcriptional repression of surviving. Biochem Biophys Res Commun. (2014) 445(1):208-213.
http://dx.doi.org/doi:10.1016/j.bbrc.2014.01.169
44. Daniel B. Stovall, Paul Cao and Guangchao Sui*. SOX7: From a developmental regulator to an emerging tumor suppressor. Histol Histopathol. (2014) 29(4):439-445.
http://www.hh.um.es/Abstracts/Vol_29/29_4/29_4_439.htm
45. Wei Wang, David Grier, Jennifer Woo, Martha Ward, Guangchao Sui, Suzy V. Torti, Frank M. Torti, and Michael W. Beaty. Ferritin H is a novel marker of early erythroid precursors and macrophages. Histopathology. (2013) 62(6):931-40.
http://dx.doi.org/ doi:10.1111/his.12101
46. Sinan Zhu, Ryan T. Mott, Elizabeth A. Fry, Pankaj Taneja, George Kulik, Guangchao Sui*, and Kazushi Inoue*. Cooperation between Dmp1-loss and cyclin D1 overexpression in breast cancer. American Journal of Pathology. (2013) 183(4):1339-1350.
http://dx.doi.org/doi:10.1016/j.ajpath.2013.06.027
47. Daniel B. Stovall, Meimei Wan, Lance D. Miller, Paul Cao, Dejan Maglic, Qiang Zhang, Martha R. Stampfer, Wennuan Liu, Jianfeng Xu and Guangchao Sui*. The Regulation of SOX7 and its Tumor Suppressive Role in Breast Cancer. American Journal of Pathology. (2013) 183(5):1645-1653.
http://dx.doi.org/doi:10.1016/j.ajpath.2013.07.025
48. Dana Yancey, Kyle C. Nelson, Daniele Baiz, Sazzad Hassan, Anabel Flores, Ashok Pullikuth, Yelena Karpova, Victoria Moore1, Guangchao Sui and George Kulik. BAD Dephosphorylation and Decreased Expression of MCL-1 Induce Rapid Apoptosis in Prostate Cancer Cells. PLoS One. (2013) 8(9):e74561. http://dx.doi.org/doi:10.1371/journal.pone.0074561
49. Daniele Baiz, Sazzad Hassan, Young A Choi, Anabel Flores, Yelena Karpova, Dana Yancey, Ashok Pullikuth, Guangchao Sui, Michel Sadelain, Waldemar Debinski and George Kulik. Combination of the PI3K Inhibitor ZSTK474 with a PSMA-Targeted Immunotoxin Accelerates Apoptosis and Regression of Prostate Cancer. Neoplasia. (2013) 15(10):1720-1183.
http://dx.doi.org/doi:10.1593/neo.13986
50. Elizabeth A. Fry, Pankaj Taneja, Dejan Maglic, Sinan Zhu, Guangchao Sui*, and Kazushi Inoue*. Dmp1α Inhibits HER2/neu-induced Mammary Tumorigenesis. PLoS One. (2013) 8(10):e77870.
http://dx.doi.org/doi:10.1371/journal.pone.0077870
51. Guorui Deng and Guangchao Sui*. Noncoding RNA in Oncogenesis: A New Era of Identifying Key Players. Int. J. Mol. Sci. (2013) 14:18319-18349. (Invited review)
http://dx.doi.org/doi:10.3390/ijms140918319
52. Weiwei Huang, Philip J. Smaldino, Qiang Zhang, Lance D. Miller, Paul Cao, Kristin Stadelman, Meimei Wan, Banabihari Giri, Ming Lei, Yoshikuni Nagamine, James P. Vaughn, Steven A. Akman and Guangchao Sui*. Yin Yang 1 contains G-quadruplex structures in its promoter and 5’-UTR and its expression is modulated by G4 Resolvase 1. Nucleic Acids Research, (2012) 40(3):1033-1049.
http://dx.doi.org/doi:10.1093/nar/gkr849
53. Shihua Wang, Jiansheng Wu, Janel Suburu, Zhennan Gu, Jiaozhong Cai, Linara S. Axanova, Scott D. Cramer, Michael J. Thomas, Donna L. Perry, Iris Edwards, Lorelei Mucci, Jennifer Sinnott, Massimo Loda, Guangchao Sui, Isabelle M. Berquin and Yong Q. Chen. Effect of Dietary Polyunsaturated Fatty Acids on Castration-resistant Pten-null Prostate Cancer. Carcinogenesis, (2012) 33(2):404-412.
http://dx.doi.org/doi:10.1093/carcin/bgr290
54. Wennuan Liu, Johan Lindberg, Guangchao Sui, Jun Luo, Tao Li, Carol Xie, Meimei Wan, Seong-Tae Kim, Aubrey Turner, Jishan Sun, Yi Zhu, Zheng Zhang, Scott D Cramer, Robert L. Vessella, S. Lilly Zheng, Henrik Grönberg, William B. Isaacs and Jianfeng Xu. Genome-wide analysis of somatic DNA copy number reveals novel CHD1-associated collaborative alterations of genomic structure in prostate cancer. Oncogene, (2012) 31(35):3939-48.
http://dx.doi.org/doi:10.1038/onc.2011.554
55. Caroline I. Schnegg, Mitra Kooshki, Fang-Chi Hsu, Guangchao Sui and Mike E. Robbins. PPARδ prevents radiation-induced proinflammatory responses in microglia via transrepression of NF-кB and inhibition of the PKCα/MEK1/2/ERK1/2/AP-1 pathway. Free Radical Biology and Medicine, (2012) 52:1734-1743.
http://dx.doi.org/10.1016/j.freeradbiomed.2012.02.032
56. Donna P. Frazier, Robert D. Kendig, Fumitake Kai, Dejan Maglic, Takayuki, Sugiyama, Rachel L. Morgan, Sarah J. Lagedrost, Guangchao Sui and Kazushi Inoue. Dmp1 physically interacts with p53 and positively regulates p53’s stability, nuclear localization and transcriptional activity. Cancer Research, (2012) 72:1740-1750.
http://dx.doi.org/doi:10.1158/0008-5472.CAN-11-2410
57. Meimei Wan, Weiwei Huang, Timothy E. Kute, Lance Miller, Qiang Zhang, Heather Hatcher, Jingxuan Wang, Daniel Stovall, Gregory B. Russell, Paul Cao, Zhiyong Deng, Wei Wang, Qingyuan Zhang, Ming Lei, Suzy Torti, Steven A. Akman and Guangchao Sui*. Yin Yang 1 plays an essential role in breast cancer and negatively regulates p27. American Journal of Pathology, (2012) 180(5):2120-2133.
http://dx.doi.org/10.1016/j.ajpath.2012.01.037
58. Min Wu, Lihong Shi, Adela Cimic, Lina Romero, Guangchao Sui, Cynthia J. Lees, J. Mark Cline, Darren F. Seals, Joseph S. Sirintrapun, Thomas P. McCoy, Jielin Sun, Seong-Tae Kim, Wennuan Liu, Donna M. Peehl, Jianfeng Xu, Scott D. Cramer. Suppression of Tak1 promotes prostate tumorigenesis. Cancer Research, (2012) 72(11):2833-2843.
http://dx.doi.org/doi:10.1158/0008-5472.CAN-11-2724
59. Shuai Tang, Meenu Mishra, Donna P. Frazier, Miranda L. Moore, Kazushi Inoue, Rajendar Deora, Guangchao Sui and Purnima Dubey. Positive and negative regulation of prostate stem cell antigen expression by Yin Yang 1 in prostate epithelial cell lines. PLoS One, (2012) 7(4): e35570.
http://dx.doi.org/doi:10.1371/journal.pone.0035570
60. Daniel Stovall and Guangchao Sui*. The Function of YY1 and its Oncogenic Role in Prostate Cancer. In: Gerhard Hamilton, eds. Advances in Prostate Cancer. InTech. 2012:563-587.
http://dx.doi.org/10.5772/53091
61. Daniel Stovall, Meimei Wan, Qiang Zhang, Purnima Dubey and Guangchao Sui*. DNA Vector-based RNA Interference to Study Gene Function in Cancer. Journal of Visualized Experiments, (2012) (64), pii: 4129.
http://dx.doi.org/doi:10.3791/4129
62. Zhiyong Deng, Guangchao Sui, Paulo Mottin Rosa and Weiling Zhao. Radiation-Induced c-Jun Activation Depends on MEK1-ERK1/2 Signaling Pathway in Microglial Cells. PLoS One, (2012) 7(5):e36739.
http://dx.doi.org/doi:10.1371/journal.pone.0036739
63. Zandra K. Pinnix, Lance D. Miller, Wei Wang, Ralph D’Agostino Jr., Tim Kute, Mark C. Willingham, Heather Hatcher, Lia Tesfay, Guangchao Sui, Xiumin Di, Suzy V. Torti, Frank M. Torti. Ferroportin and Iron Regulation in Breast Cancer Progression and Prognosis. Sci Transl Med. (2012) 22, 43ra56.
http://dx.doi.org/doi:10.1126/scitranslmed.3001127
64. Salima Daou, Nazar Mashtalir, Ian H Martel, Helen Pak, Helen Yu, Guangchao Sui, Jodi Vogel, Thomas Kristie, El Bachir Affar. Crosstalk Between O-GlcNAcylation And Proteolytic Cleavage Regulates The Host Cell Factor-1 Maturation Pathway. Proc. Natl. Acad. Sci. USA, (2011) 108(7):2747-2752.
http://dx.doi.org/doi:10.1073/pnas.1013822108
65. Sophia L Maund, Wendy W Barclay, Laura D Hover, Linara S Axanova, Guangchao Sui, Jason D Hipp, James C. Fleet, Andrew Thorburn, and Scott D Cramer. Interleukin-1α Mediates the Antiproliferative Effects of 1,25-Dihydroxyvitamin D3 in Prostate Progenitor/Stem Cells. (2011) Cancer Research, 71(15):5276-5286.
http://dx.doi.org/doi:10.1158/0008-5472.CAN-10-2160
66. Qiang Zhang, Daniel Stovall, Kazushi Inoue and Guangchao Sui*. The oncogenic role of Yin Yang 1. Critical Reviews in Oncogenesis, (2011) 16(3-4):163-197. (Invited review)
http://dx.doi.org/DOI:10.1615/CritRevOncog.v16.i3-4.30
67. Rui Fang, Andrew J. Barbera, Yufei Xu, Michael Rutenberg, Thiago Leonor, Qing Bi, Fei Lan, Pinchao Mei, Guo-Cheng Yuan, Christine Lian, Junmin Peng, Dongmei Cheng, Guangchao Sui, Ursula B. Kaiser, Yang Shi and Yujiang Geno Shi. Human LSD2/KDM1b/AOF1 Regulates Gene Transcription by Modulating Intragenic H3K4me2 Methylation. Mol. Cell, (2010) 39(2):222-233.
http://dx.doi.org/doi:10.1016/j.molcel.2010.07.008
68. Helen Yu, Nazar Mashtalir, Salima Daou, Ian Hammond-Martel, Julie Ross, Guangchao Sui, Gerald W. Hart, Frank J. Rauscher III, Elliot Drobetsky, Eric Milot, Yang Shi and El Bachir Affar. The Ubiquitin Carboxyl Hydrolase BAP1 Forms a Ternary Complex with YY1 and HCF-1 and is a Critical Regulator of Gene Expression. Mol. Cell. Biol., (2010) 30(21):5071-5085.
http://dx.doi.org/doi:10.1128/MCB.00396-10
69. Zhiyong Deng, Paul Cao, Meimei Wan and Guangchao Sui*. Yin Yang 1: a multifaceted protein beyond a transcription factor. Transcription. (2010) 1(2):81-84. (Invited review)
http://dx.doi.org/10.4161/trns.1.2.12375
70. Paul Cao, Zhiyong Deng, Meimei Wan, Weiwei Huang, Scott D Cramer, Jianfeng Xu, Ming Lei and Guangchao Sui*. MicroRNA-101 Negatively Regulates Ezh2 and Its Expression is Modulated by Androgen Receptor and HIF-1alpha/HIF-1beta. Mol. Cancer, (2010) 9(1):108.
http://dx.doi.org/doi:10.1186/1476-4598-9-108
71. Linara S. Axanova, Yong Q. Chen, Thomas McCoy, Guangchao Sui and Scott D. Cramer. 1,25-dihydroxyvitamin D3 and PI3K/AKT inhibitors synergistically inhibit growth and induce senescence in prostate cancer cells. Prostate. (2010) 70(15):1658-1671.
http://dx.doi.org/doi:10.1002/pros.21201
72. Zhiyong Deng, Meimei Wan, Paul Cao, Anuradha Rao, Scott D. Cramer and Guangchao Sui*. Yin Yang 1 Regulates the Transcriptional Activity of Androgen Receptor. Oncogene; (2009) 28:3746-3757.
http://dx.doi.org/doi:10.1038/onc.2009.231
73. Guangchao Sui*. The regulation of YY1 in tumorigenesis and its targeting potential in cancer therapy. Mol. Cell. Pharmacol. (2009) 1(3):157-176 (Invited review)
http://dx.doi.org/DOI:10.4255/mcpharmacol.09.20
74. Dohoon Kim, Minh Nguyen, Matthew Dobbin, Andre Fischer, Farahnaz Sananbenesi, Joseph Rodgers, Ivana Delalle, Joseph Baur, Guangchao Sui, Sean M Armour, Pere Puigserver, David Sinclair and Li-Huei Tsai. SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J. (2007) 26(13):3169–3179.
http://dx.doi.org/doi:10.1038/sj.emboj.7601758
75. Zhiyong Deng, Meimei Wan and Guangchao Sui*. PIASy-mediated sumoylation of Yin Yang 1 depends on their interaction but not the RING finger. Mol. Cell. Biol., (2007) 27(10):3780-3792.
http://dx.doi.org/doi:10.1128/MCB.01761-06
76. Margaret P. Luke, Guangchao Sui, Huifei Liu and Yang Shi. Yin Yang 1 physically interacts with HoxA11 and represses HoxA11-depedent transcription. J. Biol. Chem., (2006) 281:33226-33232.
http://dx.doi.org/doi:10.1074/jbc.M606584200
77. El Bachir Affar, Margaret Po-shan Luke, Frederique Gay, Dominica, Calvo, Guangchao Sui, Robert S. Weiss, En Li, and Yang Shi. Targeted ablation of Par-4 reveals a cell type-specific susceptibility to apoptosis-inducing agents. Cancer Research. (2006) 66:3456-3462.
http://dx.doi.org/doi:10.1158/0008-5472.CAN-05-0964
78. Guangchao Sui and Yang Shi. Gene silencing by a DNA vector-based RNAi technology. Methods Mol. Biol., (2005) 309:205-218.
http://dx.doi.org/doi:10.1385/1-59259-935-4:205
79. Peter Baumeister, Shengzhan Luo, William C. Skarnes, Guangchao Sui, Edward Seto, Yang Shi and Amy S. Lee. Endoplasmic reticulum stress induction of the Grp78/BiP promoter: activating mechanisms mediated by YY1 and its interactive chromatin modifiers. Mol. Cell. Biol., (2005) 25:4529-4540.
http://dx.doi.org/doi:10.1128/MCB.25.11.4529-4540.2005
80. Guangchao Sui, El Bachir Affar, Yujiang Shi, Chrystelle Brignone, Nathan R. Wall, Peng Yin, Mary Donohoe, Margaret P. Luke, Dominica Calvo, Steven R. Grossman and Yang Shi. Yin Yang 1 is a negative regulator of p53. Cell, (2004) 117:859-872.
http://dx.doi.org/doi:10.1016/j.cell.2004.06.004
81. Yujiang Shi, Junichi Sawada, Guangchao Sui, El Bachir Affar, Johnathan R. Whetstine, Fei Lan, Hidesato Ogawa, Margaret Po-Shan Luke, Yoshihiro Nakatani and Yang Shi. Coordinated histone modifications mediated by a CtBP co-repressor complex. Nature, (2003) 422:735-738.
http://dx.doi.org/doi:10.1038/nature01550
82. Guangchao Sui, Christina Soohoo, El Bachir Affar, Frederique Gay, Yujiang Shi, William C. Forrester, and Yang Shi. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc. Natl. Acad. Sci. USA, (2002) 99:5515-5520.
http://dx.doi.org/doi:10.1073/pnas.082117599
83. Dominica Calvo, Martin Vector, Frederique Gay, Guangchao Sui, Margaret P Luck, Pascle Dufourcq, Gengyun Wen, M Maduro, J Rothman and Yang Shi. A POP-1 repressor complex restricts inappropriate cell type-specific gene transcription during Caenorhabditis elegans embryogenesis. EMBO. J., (2001) 20(24):7197-7208.
http://dx.doi.org/doi:10.1093/emboj/20.24.7197.
84. Guang-Chao Sui and Björn Wiman. The B beta-sheet in the PAI-1 molecule plays an important role in regulating its stability. Thrombosis and Haemostasis, (2000) 83(6):896-901. http://www.schattauer.de/index.php?id=1268&L=1&pii=th00060896&no_cache=1
85. Helena Mångs, Guang-Chao Sui and Björn Wiman. PAI-1 stability: role of histidine residues. FEBS Letters, (2000) 475(3):192-196.
http://dx.doi.org/doi:10.1016/S0014-5793(00)01656-2
86. Guang-Chao Sui, Helena Mångs and Björn Wiman. The role of His143 to PAI-1 function. Biochim. Biophys. Acta., (1999) 1434(1):58-63.
http://dx.doi.org/doi:10.1016/S0167-4838(99)00157-0
87. Gunnar Falk, Guang-Chao Sui, Sam Schulman and Björn Wiman. Detection of a new polymorphism in the propeptide region of the PAI-1 gene in two individuals with bleeding tendencies. Fibrinolysis and Proteolysis, (1999) 13(1):26-30.
http://dx.doi.org/doi:10.1016/S0268-9499(99)90012-7
88. Guang-Chao Sui and Björn Wiman. Functional effects of single amino acid substitutions in the region Phe113 to Asp138 in the PAI-1 molecule. Biochem. J., (1998) 331(2):409-415.
http://www.biochemj.org/bj/331/0409/bj3310409.htm
89. Guang-Chao Sui and Björn Wiman. Stability of plasminogen activator inhibitor-1: role of Tyrosine221. FEBS Letters, (1998) 423(3):319-323.
http://dx.doi.org/doi:10.1016/S0014-5793(98)00115-X
90. Guang-Chao Sui, Hong Sun, Man Zhang and Mei-Hao Hu. High level expression of recombinant plasminogen activator inhibitor-1 in Escherichia coli and generation of its mutants involving Asp125, Glu128 and Glu130. Biochem. Mol. Biol. Int., (1997) 42(3):621-629.
http://www.ncbi.nlm.nih.gov/pubmed/?term=9247720
Book:
Yin Yang 1 in Metastasis, Critical Reviews™ in Oncogenesis, 22(1-2), 2017. Begell House Inc. Invited editor: Guangchao Sui. http://dx.doi.org/doi:10.1615/CritRevOncog.v22.i1-2
Patents:
Yang Shi and Guangchao Sui. Compositions and Methods of Suppressing Eukaryotic Gene Expression. Publication of US20030180756A1
Guangchao Sui
The anticancer OPB peptide: its synthesis by an expression vector and application
Patient number: ZL 2016 1 0018929.6
Application date: January 12, 2016
Date of authorization: June 7, 2019
Guangchao Sui, Cheng Yi, Jinming Shi, Dangdang Li
The technology and application of the YPB peptide to inhibit breast cancer cell proliferation and tumor growth
Patient number: ZL 2020 1 1128751.3
Application date: Oct 20, 2020
Date of authorization: July 29, 2022
